vs
CUMBERLAND PHARMACEUTICALS INC（CPIX）与泛美白银（USAS）财务数据对比。点击上方公司名可切换其他公司
泛美白银的季度营收约是CUMBERLAND PHARMACEUTICALS INC的1.4倍（$19.1M vs $13.7M），CUMBERLAND PHARMACEUTICALS INC净利率更高（-10.3% vs -82.3%，领先72.0%），CUMBERLAND PHARMACEUTICALS INC同比增速更快（31.1% vs -28.0%），CUMBERLAND PHARMACEUTICALS INC自由现金流更多（$3.0K vs $-41.3M）
坎伯兰制药是一家专科制药企业，专注于开发、生产和商业化品牌处方药物，核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域，主要运营市场为美国，为相关医护人员与患者提供服务。
泛美白银是一家总部位于加拿大的矿业企业，业务布局集中在拉丁美洲，在墨西哥、秘鲁、玻利维亚、阿根廷多国持有运营矿山及其他矿产开发项目，是美洲地区重要的贵金属开采企业。
CPIX vs USAS — 直观对比
营收规模更大
USAS
是对方的1.4倍
$13.7M
营收增速更快
CPIX
高出59.1%
-28.0%
净利率更高
CPIX
高出72.0%
-82.3%
自由现金流更多
CPIX
多$41.3M
$-41.3M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.7M | $19.1M |
| 净利润 | $-1.4M | $-15.7M |
| 毛利率 | 83.6% | 34.2% |
| 营业利润率 | -10.0% | — |
| 净利率 | -10.3% | -82.3% |
| 营收同比 | 31.1% | -28.0% |
| 净利润同比 | 25.8% | 2.8% |
| 每股收益（稀释后） | $-0.09 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPIXUSAS
| Q4 25 | $13.7M | — | ||
| Q3 25 | $8.3M | $19.1M | ||
| Q2 25 | $10.8M | — | ||
| Q1 25 | $11.7M | — | ||
| Q4 24 | $10.4M | — | ||
| Q3 24 | $9.1M | $26.5M | ||
| Q2 24 | $9.8M | — | ||
| Q1 24 | $8.5M | — |
净利润CPIXUSAS
| Q4 25 | $-1.4M | — | ||
| Q3 25 | $-1.9M | $-15.7M | ||
| Q2 25 | $-740.7K | — | ||
| Q1 25 | $1.3M | — | ||
| Q4 24 | $-1.9M | — | ||
| Q3 24 | $-1.5M | $-16.2M | ||
| Q2 24 | $-1.1M | — | ||
| Q1 24 | $-1.9M | — |
毛利率CPIXUSAS
| Q4 25 | 83.6% | — | ||
| Q3 25 | 88.1% | 34.2% | ||
| Q2 25 | 81.4% | — | ||
| Q1 25 | 87.8% | — | ||
| Q4 24 | 81.1% | — | ||
| Q3 24 | 85.4% | 23.6% | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 81.5% | — |
营业利润率CPIXUSAS
| Q4 25 | -10.0% | — | ||
| Q3 25 | -23.7% | — | ||
| Q2 25 | -6.9% | — | ||
| Q1 25 | 11.0% | — | ||
| Q4 24 | -17.7% | — | ||
| Q3 24 | -18.6% | — | ||
| Q2 24 | -10.4% | — | ||
| Q1 24 | -22.0% | — |
净利率CPIXUSAS
| Q4 25 | -10.3% | — | ||
| Q3 25 | -23.4% | -82.3% | ||
| Q2 25 | -6.8% | — | ||
| Q1 25 | 10.7% | — | ||
| Q4 24 | -18.2% | — | ||
| Q3 24 | -17.0% | -60.9% | ||
| Q2 24 | -11.0% | — | ||
| Q1 24 | -22.9% | — |
每股收益（稀释后）CPIXUSAS
| Q4 25 | $-0.09 | — | ||
| Q3 25 | $-0.13 | — | ||
| Q2 25 | $-0.05 | — | ||
| Q1 25 | $0.08 | — | ||
| Q4 24 | $-0.13 | — | ||
| Q3 24 | $-0.11 | — | ||
| Q2 24 | $-0.08 | — | ||
| Q1 24 | $-0.14 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.4M | $39.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $24.9M | $50.2M |
| 总资产 | $76.8M | $234.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CPIXUSAS
| Q4 25 | $11.4M | — | ||
| Q3 25 | $15.2M | $39.1M | ||
| Q2 25 | $16.1M | — | ||
| Q1 25 | $15.1M | — | ||
| Q4 24 | $18.0M | — | ||
| Q3 24 | $17.5M | — | ||
| Q2 24 | $17.3M | — | ||
| Q1 24 | $18.5M | — |
股东权益CPIXUSAS
| Q4 25 | $24.9M | — | ||
| Q3 25 | $26.1M | $50.2M | ||
| Q2 25 | $28.0M | — | ||
| Q1 25 | $28.7M | — | ||
| Q4 24 | $22.9M | — | ||
| Q3 24 | $24.8M | $53.1M | ||
| Q2 24 | $26.3M | — | ||
| Q1 24 | $27.5M | — |
总资产CPIXUSAS
| Q4 25 | $76.8M | — | ||
| Q3 25 | $65.9M | $234.7M | ||
| Q2 25 | $67.9M | — | ||
| Q1 25 | $69.9M | — | ||
| Q4 24 | $75.6M | — | ||
| Q3 24 | $76.7M | — | ||
| Q2 24 | $78.5M | — | ||
| Q1 24 | $81.5M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0K | $-12.5M |
| 自由现金流经营现金流 - 资本支出 | $3.0K | $-41.3M |
| 自由现金流率自由现金流/营收 | 0.0% | -216.5% |
| 资本支出强度资本支出/营收 | 0.0% | 150.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $4.8M | — |
8季度趋势，按日历期对齐
经营现金流CPIXUSAS
| Q4 25 | $3.0K | — | ||
| Q3 25 | $187.2K | $-12.5M | ||
| Q2 25 | $843.8K | — | ||
| Q1 25 | $3.9M | — | ||
| Q4 24 | $1.9M | — | ||
| Q3 24 | $475.5K | $2.4M | ||
| Q2 24 | $-855.7K | — | ||
| Q1 24 | $-2.1M | — |
自由现金流CPIXUSAS
| Q4 25 | $3.0K | — | ||
| Q3 25 | $163.4K | $-41.3M | ||
| Q2 25 | $817.3K | — | ||
| Q1 25 | $3.9M | — | ||
| Q4 24 | $1.9M | — | ||
| Q3 24 | $460.1K | $-11.2M | ||
| Q2 24 | $-862.8K | — | ||
| Q1 24 | $-2.2M | — |
自由现金流率CPIXUSAS
| Q4 25 | 0.0% | — | ||
| Q3 25 | 2.0% | -216.5% | ||
| Q2 25 | 7.5% | — | ||
| Q1 25 | 32.9% | — | ||
| Q4 24 | 18.2% | — | ||
| Q3 24 | 5.1% | -42.2% | ||
| Q2 24 | -8.8% | — | ||
| Q1 24 | -25.6% | — |
资本支出强度CPIXUSAS
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.3% | 150.8% | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.2% | 51.2% | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.5% | — |
现金转化率CPIXUSAS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.10× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
